Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019

被引:0
作者
Eri Koshi
Shoji Saito
Masaki Okazaki
Yuki Toyama
Takuji Ishimoto
Tomoki Kosugi
Hiroaki Hiraiwa
Naruhiro Jingushi
Takanori Yamamoto
Masayuki Ozaki
Yukari Goto
Atsushi Numaguchi
Yasuhiro Miyagawa
Io Kato
Nobuyuki Tetsuka
Tetsuya Yagi
Shoichi Maruyama
机构
[1] Nagoya University Graduate School of Medicine,Department of Nephrology
[2] Nagoya University Hospital,Department of Emergency and Critical Care Medicine
[3] Nagoya University Hospital,Department of Hospital Pharmacy
[4] Nagoya University Hospital,Department of Clinical Laboratory
[5] Nagoya University Hospital,Department of Infectious Diseases
来源
CEN Case Reports | 2021年 / 10卷
关键词
SARS-CoV-2; COVID-19; End-stage renal disease; Favipiravir; Hemodialysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:126 / 131
页数:5
相关论文
共 66 条
  • [11] Gou X(2017)Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase Proc Jpn Acad Ser B Phys Biol Sci undefined undefined-undefined
  • [12] Pu K(undefined)undefined undefined undefined undefined-undefined
  • [13] Chen Z(undefined)undefined undefined undefined undefined-undefined
  • [14] Guo Q(undefined)undefined undefined undefined undefined-undefined
  • [15] Dong L(undefined)undefined undefined undefined undefined-undefined
  • [16] Hu S(undefined)undefined undefined undefined undefined-undefined
  • [17] Gao J(undefined)undefined undefined undefined undefined-undefined
  • [18] Kikuchi K(undefined)undefined undefined undefined undefined-undefined
  • [19] Nangaku M(undefined)undefined undefined undefined undefined-undefined
  • [20] Ryuzaki M(undefined)undefined undefined undefined undefined-undefined